Real-World Data on Potent P2Y12 Inhibition in Patients with Suspected Chronic Coronary Syndrome, Referred for Coronary Angiography.

Erik Träff,Dimitrios Venetsanos, Karin Alpkvist,Sofia Sederholm Lawesson,Mikolaj Skibniewski,Sammy Zwackman,Joakim Alfredsson

Cardiology（2022）

引用 0|浏览2

暂无评分

摘要

In patients with CCS referred for CA and PCI if feasible, a more potent P2Y12 inhibition strategy with ticagrelor was not associated with bleeding complications or MACE compared with clopidogrel.

查看译文

关键词

Bleeding,Chronic coronary syndrome,Percutaneous coronary intervention,Platelet,Stable angina

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要